Hereditary Hemolytic Anemia: Complete ICD-11 Coding Guide

1. Introduction

Hereditary hemolytic anemia represents a heterogeneous group of genetic conditions characterized by premature destruction of red blood cells (hemolysis) due to intrinsic defects of erythrocytes transmitted in a hereditary manner. These conditions result in a significant shortening of the useful life of erythrocytes, which is normally 120 days, leading to clinical manifestations that range from asymptomatic forms to severe conditions that require regular transfusions and complex medical interventions.

The clinical importance of hereditary hemolytic anemias lies in their chronic nature and significant potential impact on patients' quality of life. These conditions affect millions of people worldwide, with varied geographic distributions depending on the specific type of genetic defect involved. Some forms are particularly prevalent in certain populations due to evolutionary factors related to protection against malaria.

From a public health perspective, the recognition and appropriate management of these conditions is fundamental to prevent serious complications such as acute hemolytic crises, iron overload, gallstone formation, leg ulcers, and cardiovascular complications. Early diagnosis allows for the implementation of preventive and therapeutic strategies that significantly improve prognosis.

Correct coding using ICD-11 is critical for multiple aspects of health care. It enables appropriate epidemiological tracking, facilitates clinical research, ensures appropriate reimbursement for services provided, enables health resource planning, and ensures continuity of care when patients transition between different medical services. Accuracy in coding is also essential for legal medical records and for identifying patients who may benefit from specific follow-up programs.

2. Correct ICD-11 Code

Code: 3A10

Description: Hereditary hemolytic anemia

Parent category: null - Congenital hemolytic anemia

This code from the ICD-11 system was developed to comprehensively classify hemolytic anemias that have a genetic origin and are transmitted hereditarily. Code 3A10 serves as the main category to group various conditions that share the common pathophysiological mechanism of premature destruction of erythrocytes due to inherited genetic defects.

The hierarchical structure of ICD-11 positions this code within the chapter on diseases of the blood and hematopoietic organs, specifically in the section on congenital hemolytic anemias. This classification reflects the modern understanding that these conditions are genetically determined, manifesting from birth, although symptoms may not be apparent immediately.

Code 3A10 functions as an "umbrella" code that encompasses different types of hereditary defects of red blood cells, including erythrocyte membrane abnormalities, enzymatic deficiencies, and other inherited structural alterations. The use of this code allows for initial classification when the specific type of hereditary hemolytic anemia has not yet been completely characterized or when a more general categorization is desired for statistical or administrative purposes.

3. When to Use This Code

The code 3A10 should be applied in specific clinical scenarios where there is confirmation or strong evidence of hemolytic anemia of hereditary origin. Here are detailed practical situations:

Scenario 1: Patient with positive family history and laboratory signs of hemolysis

A 25-year-old patient presents with chronic fatigue and intermittent jaundice since adolescence. Laboratory tests reveal anemia with hemoglobin of 9 g/dL, marked reticulocytosis, elevated indirect bilirubin, and reduced haptoglobin. Family history reveals that the father and one brother have a diagnosis of chronic anemia. Peripheral blood smear shows morphological changes suggestive of hereditary defect. In this case, while specific investigations are underway to determine the exact type, code 3A10 is appropriate.

Scenario 2: Newborn with non-immune hemolytic anemia

A neonate presents with significant jaundice in the first 48 hours of life that does not respond to conventional phototherapy. Direct and indirect Coombs tests are negative, excluding hemolytic disease from blood type incompatibility. Tests show active hemolysis with spherocytosis on the smear. Family history reveals that the mother had splenectomy in childhood for "anemia." Code 3A10 is appropriate while awaiting specific diagnostic confirmation.

Scenario 3: Patient with recurrent hemolytic crises triggered by specific factors

A 30-year-old man has recurrent episodes of acute anemia, dark urine, and jaundice after ingestion of certain medications or specific foods. Investigation reveals hereditary enzymatic deficiency. History shows a family pattern compatible with inheritance linked to the X chromosome. Code 3A10 is appropriate to document the hereditary condition.

Scenario 4: Child with chronic anemia and splenomegaly of hereditary cause

An 8-year-old child under follow-up for chronic anemia since age 2 presents with persistent splenomegaly. Multiple transfusions were necessary during infections. Genetic testing confirms mutation compatible with hereditary hemolytic anemia. Both parents are asymptomatic carriers. This is a clear case for application of code 3A10.

Scenario 5: Adult diagnosed late with compensated hemolytic anemia

A 40-year-old patient undergoes routine tests that reveal mild anemia, subclinical jaundice, and splenomegaly. Retrospectively, he reports chronic fatigue and episodes of jaundice throughout life, but never properly investigated. Tests confirm chronic hemolysis of hereditary origin. Code 3A10 appropriately documents this late diagnosis.

Scenario 6: Patient under pre-splenectomy investigation

An adolescent with confirmed hereditary hemolytic anemia, transfusion dependence, and massive splenomegaly is being evaluated for splenectomy. Preoperative documentation requires precise coding of the underlying condition. Code 3A10 is essential to justify the procedure and document the surgical indication.

4. When NOT to Use This Code

It is fundamental to understand the situations where code 3A10 should not be applied to avoid classification errors:

Acquired hemolytic anemias: Conditions such as autoimmune hemolytic anemia, drug-induced hemolytic anemia, microangiopathic hemolysis, or hemolytic anemia from mechanical trauma (prosthetic heart valves) should not use this code, as they are not hereditary. These require specific codes for acquired hemolytic anemias.

Hemolytic disease of the newborn due to incompatibility: When neonatal hemolysis results from ABO, Rh, or other antigen incompatibility between mother and fetus, specific codes for perinatal hemolytic disease should be used, not 3A10, as the mechanism is immunological and not an intrinsic hereditary defect of the erythrocyte.

Specific hemoglobinopathies already coded: Conditions such as sickle cell anemia, thalassemias, and other structural hemoglobinopathies have specific codes in ICD-11. When the specific diagnosis is known, the most precise code should be used instead of the generic code 3A10.

Anemias from other causes with familial component: Some anemias may have familial predisposition without being primarily hereditary hemolytic, such as certain forms of familial aplastic anemia or hereditary bone marrow failure syndromes. These require different coding.

Hemolysis secondary to other systemic conditions: When hemolysis occurs secondarily to hepatic, renal, infectious diseases, or other systemic conditions, even if there is some genetic component of susceptibility, the primary code should reflect the causative condition, not 3A10.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

To confirm that code 3A10 is appropriate, it is necessary to establish the presence of hemolysis and its hereditary nature. The criteria include:

Laboratory evidence of hemolysis: Reduced hemoglobin with compensatory reticulocytosis, elevated indirect bilirubin, diminished or absent haptoglobin, elevated lactate dehydrogenase (LDH), and presence of free hemoglobin in plasma or urine in severe cases.

Erythrocyte morphological alterations: The peripheral blood smear should show characteristic abnormalities such as spherocytes, elliptocytes, stomatocytes, acanthocytes, or other morphological alterations suggesting intrinsic red blood cell defect.

Confirmation of hereditary nature: Positive family history of anemia, jaundice, or splenectomy; identifiable inheritance pattern; genetic testing confirming specific mutations; or functional tests demonstrating enzymatic or erythrocyte membrane defects.

Exclusion of acquired causes: Negative Coombs test to exclude autoimmune hemolysis; absence of exposure to external hemolytic agents; exclusion of mechanical or microangiopathic causes.

Step 2: Verify specifiers

Although code 3A10 is a general category, it is important to document specific characteristics:

Severity: Classify as mild (hemoglobin > 10 g/dL, asymptomatic), moderate (hemoglobin 7-10 g/dL, intermittent symptoms), or severe (hemoglobin < 7 g/dL, transfusion dependency).

Pattern of manifestation: Compensated chronic hemolysis, intermittent acute hemolytic crises, or decompensated continuous hemolysis.

Associated complications: Presence of splenomegaly, cholelithiasis, leg ulcers, pulmonary hypertension, iron overload, or other complications that should be coded additionally.

Step 3: Differentiate from other codes

Carefully compare with similar diagnoses. If there is confirmation of hereditary spherocytosis, G6PD deficiency, pyruvate kinase deficiency, or another specific condition, use the most specific code available in ICD-11. Code 3A10 is most appropriate when the specific type has not yet been determined or for general categorization.

Check that there is no overlap with codes for structural hemoglobinopathies. Confirm that hemolysis is not secondary to another systemic condition that would be the primary diagnosis.

Step 4: Required documentation

Checklist of mandatory information:

• Detailed description of clinical symptoms and their chronology
• Complete complete blood count results with erythrocyte indices
• Values of hemolysis markers (bilirubin, LDH, haptoglobin, reticulocytes)
• Description of peripheral blood smear
• Detailed family history with pedigree when possible
• Results of specific tests performed (erythrocyte osmolarity, enzyme assay, hemoglobin electrophoresis, genetic testing)
• Coombs test and results
• Complications present or absent
• Previous treatments and response

Adequate documentation: The documentation must clearly establish the diagnosis of hemolytic anemia, demonstrate its hereditary nature, and justify why more specific codes were not used, if applicable.

6. Complete Practical Example

Clinical Case:

Sofia, 12 years old, is brought to a hematology consultation for progressive fatigue and intermittent jaundice over the past 6 months. The mother reports that the child has always been "paler" than her siblings and presents episodes of "yellowing" during colds or infections. Sofia plays sports at school, but recently has been experiencing excessive fatigue during physical activities.

In the family history, the maternal grandmother underwent splenectomy at age 35 for "blood problems" and a maternal uncle has "chronic anemia". There is no history of transfusions in the family. Sofia does not use medications regularly and denies exposures to toxins.

On physical examination, she presents moderate cutaneous-mucosal pallor, mild icterus of the sclera, and palpable splenomegaly 4 cm below the left costal margin. There is no hepatomegaly, lymphadenomegaly, or other significant abnormalities.

Initial laboratory tests:

• Hemoglobin: 8.2 g/dL
• Hematocrit: 25%
• MCV: 82 fL (normal)
• MCHC: 36% (slightly elevated)
• Reticulocytes: 12% (markedly elevated)
• Leukocytes and platelets: normal
• Total bilirubin: 3.8 mg/dL (indirect: 3.2 mg/dL)
• LDH: 580 U/L (elevated)
• Haptoglobin: undetectable
• Direct Coombs test: negative

Peripheral blood smear: Presence of numerous spherocytes, marked polychromasia, absence of sickle cells or other abnormal red blood cells.

Osmotic fragility test: Increased, confirming abnormality of erythrocyte membrane.

Complementary investigation: Genetic tests requested for genes related to erythrocyte membrane defects, with results pending.

Coding Step by Step:

Analysis of criteria:

1. Confirmed hemolysis: Anemia with compensatory reticulocytosis, elevated indirect bilirubin, increased LDH, and undetectable haptoglobin establish active hemolysis.

2. Hereditary nature: Strongly positive family history (grandmother with splenectomy, uncle with anemia), pattern compatible with autosomal dominant inheritance, presence since childhood.

3. Intrinsic erythrocyte defect: Negative Coombs test excludes autoimmune cause; spherocytes on smear and increased osmotic fragility indicate membrane defect; absence of external hemolytic exposures.

4. Exclusion of other causes: No evidence of structural hemoglobinopathy, acute infection causing hemolysis, or other acquired causes.

Code selected: 3A10 - Hereditary hemolytic anemia

Complete justification:

The code 3A10 is appropriate at this time because, although the clinical and laboratory presentation is highly suggestive of hereditary spherocytosis, confirmatory genetic tests are still pending. Code 3A10 allows adequate documentation of the condition as hereditary hemolytic anemia while specific characterization is underway.

The presence of chronic compensated hemolysis with decompensation during infections, positive family history, spherocytes on smear, and increased osmotic fragility firmly establish the diagnosis of hereditary hemolytic anemia. The negative Coombs test excludes autoimmune causes.

Applicable complementary codes:

• Code for splenomegaly (as a manifestation of the condition)
• Code for jaundice (if coding of symptoms is necessary)
• When genetic results confirm the specific type, the code may be updated to a more specific category, if available in ICD-11

This coding allows appropriate follow-up, justifies additional investigations, and establishes the basis for therapeutic planning, including possible future splenectomy if there is progression of transfusion dependence.

7. Related Codes and Differentiation

Within the Same Category:

Code 3A10 functions as the superior category for hereditary hemolytic anemias. More specific codes within this category may include:

Erythrocyte membrane defects: Hereditary spherocytosis, hereditary elliptocytosis, hereditary stomatocytosis and other membranopathies have specific codes when precise diagnosis is established.

Enzymatic deficiencies: Glucose-6-phosphate dehydrogenase (G6PD) deficiency, pyruvate kinase deficiency and other erythrocyte enzymopathies have distinct codes when confirmed by specific tests.

Other hereditary hemolytic anemias: Rare conditions such as hereditary paroxysmal nocturnal hemoglobinuria or other specific forms have their own coding.

Differential Diagnoses:

Autoimmune hemolytic anemia (different code): Distinguished by positive Coombs test, absence of family history, onset generally in adulthood and response to immunosuppression. The acquired nature and autoimmune mechanism are fundamental for differentiation.

Structural hemoglobinopathies (separate specific codes): Sickle cell anemia and thalassemias have separate specific codes. They differ by abnormal hemoglobin electrophoresis, specific inheritance patterns and characteristic clinical manifestations such as vaso-occlusive crises in sickle cell disease.

Microangiopathic hemolytic anemia (different code): Conditions such as thrombotic thrombocytopenic purpura or hemolytic-uremic syndrome present schistocytes on blood smear, associated thrombocytopenia and absence of family history, clearly differentiating them from hereditary forms.

Drug-induced hemolysis (different code): Clear history of medication exposure, resolution after discontinuation of the causative agent and absence of family history or persistent morphological alterations distinguish this condition.

8. Differences with ICD-10

In the ICD-10 system, hereditary hemolytic anemias were coded primarily under:

D58 - Other hereditary hemolytic anemias: This was the closest equivalent code to 3A10 in ICD-11. Subdivisions included D58.0 (hereditary spherocytosis), D58.1 (hereditary elliptocytosis), D58.2 (other hemoglobinopathies), D58.8 (other specified hereditary hemolytic anemias) and D58.9 (unspecified hereditary hemolytic anemia).

Main changes in ICD-11:

ICD-11 introduces a clearer and more logical hierarchical structure, better separating congenital hemolytic anemias from acquired ones. The coding system allows greater specificity through extensions and postcoordinated modifiers, making it possible to document severity, complications, and specific characteristics in more detail.

Terminology was updated to reflect modern genetic and molecular knowledge. ICD-11 facilitates linkage with genomic databases and allows better tracking of specific phenotypes. Increased granularity enables more precise research and more refined epidemiological analyses.

Practical impact:

For healthcare professionals, the transition requires familiarization with the new code structure. Electronic health record systems need to be updated to support ICD-11 coding. Greater specificity allows more accurate documentation, but also requires greater detailed diagnostic knowledge.

For reimbursement and billing purposes, the transition may temporarily affect established processes until administrative systems fully adapt. Backward compatibility with ICD-10 is important during transition periods to maintain continuity in longitudinal studies and historical records.

9. Frequently Asked Questions

1. How is hereditary hemolytic anemia diagnosed?

Diagnosis is based on a combination of clinical manifestations (chronic anemia, jaundice, splenomegaly), laboratory evidence of hemolysis (reticulocytosis, elevated indirect bilirubin, low haptoglobin), morphological alterations on peripheral blood smear, and confirmation of hereditary nature through positive family history and/or genetic testing. Specialized tests such as osmotic fragility, erythrocyte enzyme assays, and molecular analysis may be necessary for specific characterization of the defect.

2. Is treatment available in public health systems?

Availability varies according to local resources, but fundamental treatments such as folic acid supplementation, blood transfusions when necessary, and prophylactic antibiotic therapy post-splenectomy are generally available in public health systems. Splenectomy, when indicated, is a standard surgical procedure accessible in most services. More specialized therapies such as iron chelation may have variable availability. Genetic counseling is an important component of comprehensive care.

3. How long does treatment last?

Hereditary hemolytic anemias are chronic conditions that require lifelong follow-up. Treatment is not curative but rather supportive and aimed at preventing complications. Patients with mild forms may require only periodic monitoring and folic acid supplementation. Moderate to severe forms may require intermittent or regular transfusions. After splenectomy, which can significantly reduce hemolysis in selected cases, follow-up remains necessary to monitor complications and infections.

4. Can this code be used in medical certificates?

Yes, code 3A10 can and should be used in official medical documentation, including certificates, when appropriate. For certificates justifying absences or activity limitations, it is important to include not only the code but also a clear description of clinical manifestations and resulting functional limitations. In situations of acute hemolytic crises or complications, additional documentation detailing severity and need for leave is recommended.

5. Can children with this condition practice sports?

The capacity for physical activities depends on the severity of anemia and degree of compensation. Patients with mild, well-compensated forms can generally participate in regular physical activities with appropriate monitoring. Those with more severe anemia may experience fatigue and exercise intolerance, requiring individualized limitations. Cardiac evaluation may be necessary before competitive activities. Adequate hydration and avoiding extreme conditions are important. Decisions should be individualized with medical guidance.

6. Can the condition worsen over time?

The natural history varies according to the specific type of hereditary hemolytic anemia. Some forms remain relatively stable throughout life, while others may show progression. Factors that may cause decompensation include infections (especially viral), pregnancy, exposure to oxidant medications, and transient aplastic crises. Chronic complications such as iron overload, cholelithiasis, and pulmonary hypertension may develop over time. Regular follow-up allows early detection and management of complications.

7. Is there a risk of transmission to children?

Yes, being hereditary conditions, there is a risk of transmission to offspring. The inheritance pattern varies: some forms are autosomal dominant (50% chance of transmission), others autosomal recessive (carrier parents have 25% chance of affected child), and some X-linked. Genetic counseling is fundamental for affected couples or those with family history, allowing understanding of risks and reproductive options. Prenatal testing may be available for severe forms when specific mutations are known.

8. What are warning signs to seek urgent care?

Patients and family members should be instructed to seek immediate care if there is: sudden intense pallor, marked jaundice, very dark or reddish urine, high fever (especially in splenectomized patients), intense abdominal pain, progressive shortness of breath, mental confusion, or neurological symptoms. These may indicate acute hemolytic crisis, serious infection, aplastic crisis, or other serious complications requiring urgent evaluation and treatment. Splenectomized patients have increased risk of serious infections and need special attention to infectious signs.

---

Conclusion:

Appropriate coding of hereditary hemolytic anemia using ICD-11 code 3A10 is fundamental for accurate documentation, continuity of care, and appropriate management of these patients. Understanding when to use this code, differentiating it from similar conditions, and properly documenting clinical characteristics ensures quality care and enables effective epidemiological tracking of these important hereditary hematological conditions.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Hereditary hemolytic anemia
2. 🔬 PubMed Research on Hereditary hemolytic anemia
3. 🌍 WHO Health Topics
4. 📊 Clinical Evidence: Hereditary hemolytic anemia
5. 📋 Ministry of Health - Brazil
6. 📊 Cochrane Systematic Reviews

References verified on 2026-02-04